Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 492 is a putative non-coding RNA classified as a pseudogene of the 5S ribosomal RNA (5S rRNA) gene family. Unlike functional 5S rRNA genes, which are an integral part of the ribosome's large subunit and play a key structural and regulatory role in protein synthesis[1][3], ribosomal RNA pseudogenes do not typically produce functional RNA molecules and are generally considered transcriptionally inactive remnants arising from gene duplication or retrotransposition events. There is no evidence that RNA5SP492 encodes a protein or produces a functional non-coding RNA, nor is it recognized as a direct therapeutic target, biomarker, or disease regulator. Additional context: 5S rRNA genes themselves play critical structural roles within ribosomes by facilitating communication and coordination between various functional centers involved in translation[1][3]. Pseudogenes can sometimes have regulatory or competitive roles (for example, as competitive endogenous RNAs in cancer biology[2][4]), but there is currently no evidence for such a function in the case of RNA5SP492.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 492 (RNA5SP492).